Frederick G. Hayden

48.1k total citations · 14 hit papers
237 papers, 24.2k citations indexed

About

Frederick G. Hayden is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Frederick G. Hayden has authored 237 papers receiving a total of 24.2k indexed citations (citations by other indexed papers that have themselves been cited), including 204 papers in Epidemiology, 49 papers in Infectious Diseases and 38 papers in Immunology. Recurrent topics in Frederick G. Hayden's work include Influenza Virus Research Studies (161 papers), Respiratory viral infections research (148 papers) and Viral Infections and Immunology Research (29 papers). Frederick G. Hayden is often cited by papers focused on Influenza Virus Research Studies (161 papers), Respiratory viral infections research (148 papers) and Viral Infections and Immunology Research (29 papers). Frederick G. Hayden collaborates with scholars based in United States, United Kingdom and Switzerland. Frederick G. Hayden's co-authors include Larisa V. Gubareva, Laurent Kaiser, Jack M. Gwaltney, Alan Hay, Michael G. Ison, Nahoko Shindo, Barry M. Farr, Timothy M. Uyeki, Penelope Ward and Stephen E. Straus and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Frederick G. Hayden

237 papers receiving 23.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

2010 834 citations Frederick G. Hayden et al. profile →
The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children

1998 697 citations Frederick G. Hayden et al. profile →
Resistant influenza A viruses in children treated with oseltamivir: descriptive study

2004 611 citations Frederick G. Hayden et al. profile →
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

2018 595 citations Frederick G. Hayden, Simon Portsmouth et al. profile →
Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections

1997 575 citations Frederick G. Hayden et al. profile →
Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.

1998 565 citations Frederick G. Hayden, Roschelle Fritz et al. Journal of Clinical Investigation profile →
Influenza virus neuraminidase inhibitors

2000 558 citations Larisa V. Gubareva, Laurent Kaiser et al. profile →
Oral oseltamivir treatment of influenza in children

2001 541 citations Richard J. Whitley, Frederick G. Hayden et al. The Pediatric Infectious Disease Journal profile →
Kinetics of Influenza A Virus Infection in Humans

2006 524 citations Frederick G. Hayden et al. profile →
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

2018 492 citations Frederick G. Hayden, Michael G. Ison et al. Clinical Infectious Diseases profile →
Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America

2009 468 citations Frederick G. Hayden et al. Clinical Infectious Diseases profile →
Middle East Respiratory Syndrome

2017 373 citations Yaseen M. Arabi, Frederick G. Hayden et al. profile →
The hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infection

2017 294 citations Frederick G. Hayden et al. Influenza and Other Respiratory Viruses profile →
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

2019 229 citations Frederick G. Hayden, Michael G. Ison et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Frederick G. Hayden

Since Specialization

Citations

This map shows the geographic impact of Frederick G. Hayden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick G. Hayden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick G. Hayden more than expected).

Fields of papers citing papers by Frederick G. Hayden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick G. Hayden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick G. Hayden. The network helps show where Frederick G. Hayden may publish in the future.

Co-authorship network of co-authors of Frederick G. Hayden

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick G. Hayden. A scholar is included among the top collaborators of Frederick G. Hayden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick G. Hayden. Frederick G. Hayden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial 2024 ·Influenza and Other Respiratory Viruses ·Hideyuki Ikematsu, (unknown), Masaya Saito, Masahiro Kinoshita, (unknown), (unknown), (unknown), (unknown), Frederick G. Hayden	5
2	A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA) 2024 ·Clinical Infectious Diseases ·Susanna K. Tan, (unknown), (unknown), Maria L. Agostini, (unknown), Christy M. Hebner, Wendy W. Yeh, Phillip S. Pang, Jaynier Moya, Charles Fogarty, (unknown), Frederick G. Hayden	7
3	Critical care management of adults with community-acquired severe respiratory viral infection 2020 ·Intensive Care Medicine ·Yaseen M. Arabi, Robert Fowler, Frederick G. Hayden	153
4	Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial 2020 ·The Lancet Infectious Diseases ·Michael G. Ison, Simon Portsmouth, Yuki Yoshida, Takao Shishido, (unknown), Kenji J. Tsuchiya, Takeki Uehara, Frederick G. Hayden	166
5	Report of the ‘Mechanisms of lung injury and immunomodulator interventions in influenza’ workshop, 21 March 2010, Ventura, California, USA* 2011 ·Influenza and Other Respiratory Viruses ·Wendy Howard, Malik Peiris, Frederick G. Hayden	8
6	Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials 2009 ·Vaccine ·Frederick G. Hayden, Wendy Howard, Laszlo Palkonyay, Marie Paule Kiény	23
7	Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection 2006 ·Antiviral Research ·Vasiliy P. Mishin, Frederick G. Hayden, Kathy L. Signorelli, Larisa V. Gubareva	4
8	Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors 2005 ·Antimicrobial Agents and Chemotherapy ·Vasiliy P. Mishin, Frederick G. Hayden, Larisa V. Gubareva	164
9	Clinical Issues and Research in Respiratory Failure from Severe Acute Respiratory Syndrome 2005 ·American Journal of Respiratory and Critical Care Medicine ·Mitchell M. Levy, (unknown), Gordon R. Bernard, Rob Fowler, Teri J. Franks, Frederick G. Hayden, Rita F. Helfand, Stephen E. Lapinsky, Thomas R. Martin, Michael S. Niederman, Gordon D. Rubenfeld, Arthur S. Slutsky, Thomas E. Stewart, Barbara Styrt, Bruce Thompson, Andrea L. Harabin	42
10	Pandemic Influenza 2004 ·The Pediatric Infectious Disease Journal ·Frederick G. Hayden	39
11	Viral infections in immunocompromised patients: whatʼs new with respiratory viruses? 2002 ·Current Opinion in Infectious Diseases ·Michael G. Ison, Frederick G. Hayden	127
12	Oral oseltamivir treatment of influenza in children breakdown → 2001 ·The Pediatric Infectious Disease Journal ·Richard J. Whitley, Frederick G. Hayden, Keith S. Reisinger, Nancy L. Young, Regina Dutkowski, David Ipe, Roger Mills, Penelope Ward	541
13	Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with Oseltamivir 2001 ·The Journal of Infectious Diseases ·Larisa V. Gubareva, Laurent Kaiser, Mikhail Matrosovich, (unknown), Frederick G. Hayden	260
14	Advances in the Prophylaxis and Treatment of Influenza Illness 2000 ·The American Journal of Managed Care ·Frederick G. Hayden	4
15	Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. breakdown → 1998 ·Journal of Clinical Investigation ·Frederick G. Hayden, Roschelle Fritz, (unknown), W. Gregory Alvord, Warren Strober, Stephen E. Straus	565
16	Middle Ear Abnormalities during Natural Rhinovirus Colds in Adults 1993 ·The Journal of Infectious Diseases ·(unknown), (unknown), (unknown), Frederick G. Hayden	35
17	Disseminated Herpes Zoster in the Immunocompromised Host: A Comparative Trial of Acyclovir and Vidarabine 1992 ·The Journal of Infectious Diseases ·Richard J. Whitley, J. W. Gnann, Daniel R. Hinthorn, (unknown), Richard B. Pollard, Frederick G. Hayden, Grégory Mertz, Michael N. Oxman, Seng-Jaw Soong, (unknown)	66
18	Comparative Susceptibility of Respiratory Viruses to Recombinant Interferons-α _2b and -β 1989 ·Journal of Interferon Research ·Steven J. Sperber, Frederick G. Hayden	22
19	Modulation of thymosin alpha 1 and thymosin beta 4 levels and peripheral blood mononuclear cell subsets during experimental rhinovirus colds. 1989 ·PubMed ·Judith Hsia, Marcelo B. Sztein, Paul H. Naylor, Gaëlle Simon, A L Goldstein, Frederick G. Hayden	15
20	Alterations of the Eustachian Tube, Middle Ear, and Nose in Rhinovirus Infection 1989 ·Archives of Otolaryngology - Head and Neck Surgery ·Timothy McBride, (unknown), Frederick G. Hayden, Jack M. Gwaltney	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact